Jiang, Y., Dai, J., Zhang, H., Sottnik, J. L., Keller, J. M., Escott, K. J., . . . Keller, E. T. (2013). Activation of the Wnt pathway through use of AR79, a glycogen synthase kinase 3β inhibitor, promotes prostate cancer growth in soft tissue and bone.
Chicago Stili AlıntıJiang, Yuan, et al. Activation of the Wnt Pathway Through Use of AR79, a Glycogen Synthase Kinase 3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone. 2013.
MLA AlıntıJiang, Yuan, et al. Activation of the Wnt Pathway Through Use of AR79, a Glycogen Synthase Kinase 3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and Bone. 2013.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..